Zofran and Prinzide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zofran (ondansetron hydrochloride) and Prinzide (hydrochlorothiazide; lisinopril). Common drug interactions include breast cancer among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Zofran and Prinzide. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

What is Prinzide?

Prinzide has active ingredients of hydrochlorothiazide; lisinopril. It is often used in high blood pressure. eHealthMe is studying from 2,218 Prinzide users. Check the latest studies of Prinzide.



On Jul, 17, 2026

49 people who take Zofran and Prinzide together, and have interactions are studied.

Zofran and Prinzide drug interactions.

What are the common drug interactions of Zofran and Prinzide, by gender? *:

female:

  1. Breast cancer
  2. Carbohydrate antigen 27.29 increased
  3. Cataract (clouding of the lens inside the eye)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Ear infection
  6. Fluid retention (an abnormal accumulation of fluid in the blood)
  7. Gastrointestinal pain
  8. Headache (pain in head)
  9. Hypoacusis (loss of hearing)
  10. Memory impairment

male:

  1. Blood creatinine increased
  2. Fatigue (feeling of tiredness)
  3. Decreased appetite
  4. Epistaxis (bleed from the nose)
  5. Gastroenteritis escherichia coli (inflammation of stomach and intestine caused by escherichia coli infection)
  6. Lactic acidosis (low ph in body tissues)
  7. Polyp
  8. Venous thrombosis limb (blood clot that forms in a vein in the limb)
  9. Acne (skin problems that cause pimples)
  10. Adrenal mass

What are the common drug interactions of Zofran and Prinzide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cellulitis (infection under the skin)
  2. Cellulitis gangrenous (localized inflammation of the soft or connective tissue with considerable mass of body tissue dies (necrosis))
  3. Gangrene (body tissue dies)
  4. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  5. Perineal abscess
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Urinary tract infection
  8. Vulval abscess
  9. Vulval cellulitis (inflammation of skin around vagina)
  10. Vulvitis (inflammation of the vulva)

50-59:

  1. Cardiac arrest
  2. Cardiogenic shock (inadequate circulation of blood)
  3. Constipation
  4. Diarrhoea
  5. Fatigue (feeling of tiredness)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Glioblastoma multiforme (most common and deadliest of malignant primary brain tumours in adults)
  8. Headache (pain in head)
  9. Irritability
  10. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

60+:

  1. Diarrhoea
  2. Blood creatinine increased
  3. Chronic kidney disease
  4. Abdominal discomfort
  5. Abdominal distension
  6. Blood glucose increased
  7. Epistaxis (bleed from the nose)
  8. Gastroenteritis escherichia coli (inflammation of stomach and intestine caused by escherichia coli infection)
  9. Lactic acidosis (low ph in body tissues)
  10. Pneumonia

What are the existing conditions these people have? *

  1. Pain: 12 people, 24.49%
  2. Stress And Anxiety: 10 people, 20.41%
  3. Nausea And Vomiting: 8 people, 16.33%
  4. Constipation: 7 people, 14.29%
  5. Type 2 Diabetes: 6 people, 12.24%
  6. Sleep Disorder: 6 people, 12.24%
  7. Diabetes: 6 people, 12.24%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 10.20%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 8.16%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 8.16%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran and Prinzide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zofran and Prinzide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prinzide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prinzide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron hydrochloride and hydrochlorothiazide; lisinopril (the active ingredients of Zofran and Prinzide, respectively), and Zofran and Prinzide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: